Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BRINEURA safely and effectively. See full prescribing information for BRINEURA. BRINEURA (cerliponase alfa) injection, for intraventricular use Initial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-prescription
BRINEURA is indicated to slow the loss of ambulation in pediatric patients with neuronal ceroid lipofuscinosis type 2 (CLN2 disease), also known as tripeptidyl peptidase 1 (TPP1) deficiency.
- generic_name
- cerliponase alfa
- brand_name
- Intraventricular Electrolytes
- product_names
- cerliponase alfa, Intraventricular Electrolytes
- ndc
- 68135-811, 68135-811-02, 68135-500, 68135-500-00, 68135-495, 68135-495-04
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en